Correlation Between Inozyme Pharma and Akebia Ther
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Akebia Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Akebia Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Akebia Ther, you can compare the effects of market volatilities on Inozyme Pharma and Akebia Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Akebia Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Akebia Ther.
Diversification Opportunities for Inozyme Pharma and Akebia Ther
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Inozyme and Akebia is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Akebia Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akebia Ther and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Akebia Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akebia Ther has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Akebia Ther go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Akebia Ther
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Akebia Ther. In addition to that, Inozyme Pharma is 2.08 times more volatile than Akebia Ther. It trades about -0.3 of its total potential returns per unit of risk. Akebia Ther is currently generating about 0.24 per unit of volatility. If you would invest 179.00 in Akebia Ther on November 9, 2024 and sell it today you would earn a total of 37.00 from holding Akebia Ther or generate 20.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Akebia Ther
Performance |
| Timeline |
| Inozyme Pharma |
| Akebia Ther |
Inozyme Pharma and Akebia Ther Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Akebia Ther
The main advantage of trading using opposite Inozyme Pharma and Akebia Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Akebia Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akebia Ther will offset losses from the drop in Akebia Ther's long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Akebia Ther vs. Protalix Biotherapeutics | Akebia Ther vs. Cidara Therapeutics | Akebia Ther vs. X4 Pharmaceuticals | Akebia Ther vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |